Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Oct. 28, 2011		Oct. 29, 2010	Oct. 30, 2009
Operating Activities:
Net income (loss)	$ (138,601)		$ 222,056	$ 160,153
Adjustments to reconcile net income (loss) to net cash (used in)/provided by operating activities:
Depreciation	90,109		74,039	75,287
Amortization	7,638		7,273	7,575
Stock-based compensation	9,783		9,011	9,385
Deferred income taxes	(35,906)		3,240	18,397
Impairment of Goodwill and Intangible Assets	409,714	[1]
(Gain)/loss on asset divestitures	(420)		(12,419)	940
Changes in certain assets and liabilities, net of effects of acquired businesses:
(Increase)/decrease in accounts and notes receivable	(32,038)		(58,892)	40,530
(Increase)/decrease in inventories and other assets	30,667		(40,251)	37,751
Increase/(decrease) in trade accounts payable and other accrued liabilities	2,641		67,514	15,045
Increase/(decrease) in income taxes payable	(23,979)		21,900	(17,554)
Increase/(decrease) in other deferred liabilities	(31,925)		(20,102)	(29,371)
Settlement of Treasury Lock Contracts				11,600
Other	3,491		(7,488)	7,957
Net Cash (Used In)/Provided By Operating Activities	291,174		265,881	337,695
Investing Activities:
Purchases of property, plant and equipment	(66,469)		(67,732)	(57,897)
Acquisition of businesses, net of cash acquired	(30,579)		(143,365)
Cash proceeds on disposal of assets	3,649		27,808	581
(Increase)/decrease in restricted cash	(3,589)		(12,574)
Purchase of Huarun redeemable stock				(45,047)
Net Cash (Used In)/Provided By Investing Activities	(96,988)		(195,863)	(102,363)
Financing Activities:
Proceeds from issuance of debt			40,984	296,772
Net change in other borrowings	(53,408)		(132)	(346,623)
Net proceeds from issuance of commercial paper	153,955
Proceeds from sale of treasury stock	41,087		41,917	23,956
Treasury stock purchases	(241,831)		(118,671)	(54,387)
Excess tax benefit from stock-based compensation	7,239		4,791	1,343
Payments on deferred liability - excess cash - Huarun				(4,818)
Dividends paid	(68,164)		(63,279)	(60,116)
Purchase of equity award shares	(11,454)
Net Cash (Used In)/Provided By Financing Activities	(172,576)		(94,390)	(143,873)
Increase/(Decrease) in Cash and Cash Equivalents	21,610		(24,372)	91,459
Effect of exchange rate changes on Cash and Cash Equivalents	(11,064)		4,274	6,187
Cash and Cash Equivalents at Beginning of Period	167,621		187,719	90,073
Cash and Cash Equivalents at End of Period	$ 178,167		$ 167,621	$ 187,719

[1] For more information on the Impairment of Goodwill and Intangible Assets see Note 1 and Note 8 in Notes to Consolidated Financial Statements.